Loading
NASDAQConsumer DefensiveHousehold & Personal Products
Latest quote
$7.135
+$0.065 · +0.92%
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
Previous close
$7.135
+$0.065 · +0.92%
Regular session · ET · Market data may be delayed.
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
Day range
Current $7.135
52-week range
Current $7.135
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
77
Undervalued
Sentiment
60
Mixed
Risk
40
Moderate Risk
Momentum
44
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
Day range
Current $7.135
52-week range
Current $7.135
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10.55M USD | 12.18M USD | 10.89M USD | 12.7M USD | 13.93M USD |
| Cost of goods sold | 5.51M USD | 5.72M USD | 5.48M USD | 6M USD | 5.75M USD |
| Gross profit | 5.03M USD | 6.46M USD | 5.41M USD | 6.7M USD | 8.18M USD |
| Research and development | 463.64K USD | 456.78K USD | 463.99K USD | 490.77K USD | 478.64K USD |
| Operating expenses | 2.79M USD | 2.81M USD | 2.54M USD | 2.66M USD | 2.51M USD |
| Interest income | 365.31K USD | 434.68K USD | 306.65K USD | 236.7K USD | 233.86K USD |
| Interest expense | — | — | — | 1.62M USD | — |
| Depreciation and amortization | 108.2K USD | 95.89K USD | 105.68K USD | 135.4K USD | 145.98K USD |
| Operating income | 2.24M USD | 3.65M USD | 2.86M USD | 4.04M USD | 5.67M USD |
| Net income | 2.11M USD | 3.25M USD | 2.58M USD | 2.57M USD | 4.66M USD |
Company facts updated Sep 8, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI636.36K0.00%2.3T USD0.03%$379.73-0.32%
Vanguard Extended Market ETFVXF253.86K0.00%93.7B USD0.05%$242.66+0.14%
U.S. Micro Cap Portfolio ETFDFMC228.18K0.00%7.98B USD0.43%$60.36+0.60%
iShares Micro-Cap ETFIWC78.91K0.01%1.49B USD0.60%$196.25+0.69%
Dimensional - US Small Cap ETFDFAS74K0.00%15.67B USD0.26%$82.20+0.18%
Dimensional - US Sustainability Core 1 ETFDFSU10.25K0.00%2.43B USD0.15%$48.42-0.39%
Dimensional - US Core Equity 1 ETFDCOR8.18K0.00%3.56B USD0.14%$84.83-0.20%
Dimensional - US Core Equity 2 ETFDFAC1.66K0.00%49.56B USD0.17%$45.72-0.09%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFU.S. Micro Cap Portfolio ETFDFMCiShares Micro-Cap ETFIWCDimensional - US Small Cap ETFDFASDimensional - US Sustainability Core 1 ETFDFSUDimensional - US Core Equity 1 ETFDCORDimensional - US Core Equity 2 ETFDFACAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
